Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,102.80
(
2.39%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
101.21
(
-5.47%
)
Bitcoin
72,098.32
(
4.71%
)
News Focus
News Focus
Post# of 820700
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TTsr

Send PM Follow Ignore
Followers 14
Posts 682
Boards Moderated 0
Alias Born 12/17/2022

TTsr

Re: User-840664 post# 678179

Tuesday, 03/12/2024 10:13:16 PM

Tuesday, March 12, 2024 10:13:16 PM

Post# of 820700
Then why are the powers-that-be at Oncovir so excited about using their product with DCvax…

“Oncovir is uniquely positioned in the cancer and infectious disease market, we can add significant clinical value to new and approved vaccines, including dendritic cell vaccines.”

https://www.laweekly.com/oncovir-inc-is-pushing-the-boundaries-of-medical-innovation-with-hiltonol/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News